Title:
Team Grant: E-Rare-3 Joint Transnational Call
Agreement Value:
$106,920.00
Agreement Date:
Jan 1, 2021 - Dec 31, 2023
Description:
The specific objectives of this funding opportunity are:
• Enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients.
• Accelerate diagnosis and/or explore disease progression and mechanisms of rare diseases.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
236-2020-2021-Q4-00269
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:
Amendment 1: Agreement Value in CAD.
Amendment Date
Dec 31, 2021
Recipient's Legal Name:
Al-Awar, Rima S
Research Organization:
Ontario Institute for Cancer Research (Toronto, Ontario)|Institut ontarien de recherche sur le cancer
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.